BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 8998798)

  • 1. [Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of symptomatic portal hypertension].
    Krajina A; Hůlek P; Eliás P; Michl A; Zizka J; Nozicka J; Vanásek T; Lojík M; Niangová I; Volfová M; Pozler O; Erben J; Papík Z; Bures J
    Cas Lek Cesk; 1996 Sep; 135(18):584-8. PubMed ID: 8998798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The transjugular intrahepatic portosystemic stent-shunt (TIPS) in the management of portal hypertension. A preliminary report].
    Aguilar Ramírez JR; Alcantara Peraza RA; Hernández Pérez RE; Gómez Maganda y Silva T; Heredia Jarero NM; Torres Valadez F; Gómez del Campo López A
    Rev Gastroenterol Mex; 1994; 59(3):218-22. PubMed ID: 7716362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
    Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension].
    Astrup LB; Solvig J; Cwikiel W
    Ugeskr Laeger; 1998 Mar; 160(11):1627-32. PubMed ID: 9522655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transjugular placement of an intrahepatic portosystemic shunt as current treatment for complications of portal hypertension].
    Buiskool RA; Pieterman H; van Buuren HR; Laméris JS
    Ned Tijdschr Geneeskd; 1996 Mar; 140(12):659-64. PubMed ID: 8668239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results.
    Pozler O; Krajina A; Vanicek H; Hulek P; Zizka J; Michl A; Elias P
    Hepatogastroenterology; 2003; 50(52):1111-4. PubMed ID: 12845992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation.
    Cosenza CA; Hoffman AL; Friedman ML; Sher LS; Lopez RR; Van Allen R; Brown DH; Fraiman MH; Arnaout W; Vierling J; Makowka L
    Am Surg; 1996 Oct; 62(10):835-9. PubMed ID: 8813166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunt: early experience with a flexible trocar/catheter system.
    Maynar M; Cabrera J; Pulido-Duque JM; Reyes R; Górriz E; Rostagno R; Ferral H; Castañeda-Zúñiga WR
    AJR Am J Roentgenol; 1993 Aug; 161(2):301-6. PubMed ID: 8333367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent position of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension.
    Svoboda P; Kantorova I; Brhelova H; Vasickova J; Ochmann J
    Hepatogastroenterology; 1997; 44(15):647-55. PubMed ID: 9222665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [First experience with transjugular intrahepatic porto-systemic shunt (TIPS)].
    Lázár I; Petó J; Kristóf T
    Magy Seb; 2002 Feb; 55(1):9-15. PubMed ID: 11930565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic vascular shunting for portal hypertension: early experience with the transjugular intrahepatic porto-systemic shunt.
    Rogers CG; Paolini RM; O'Leary JP
    Am Surg; 1994 Feb; 60(2):114-7. PubMed ID: 8304641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation.
    Wils A; van der Linden E; van Hoek B; Pattynama PM
    J Clin Gastroenterol; 2009; 43(10):982-4. PubMed ID: 19417681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in portal venous pressure by transjugular intrahepatic portosystemic shunt for treatment of hemorrhagic stomal varices.
    Deipolyi AR; Kalva SP; Oklu R; Walker TG; Wicky S; Ganguli S
    AJR Am J Roentgenol; 2014 Sep; 203(3):668-73. PubMed ID: 25148174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indications and contraindications.
    Brown RS; Lake JR
    Adv Intern Med; 1997; 42():485-504. PubMed ID: 9048128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
    Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.